Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1517, 2005-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A new mechanism of atorvastatin beneficial in CAD?
Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. :
Access to resources
Recommend
ATP III update targets high-risk patients, statins market to benefit?
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
ATP III update targets high-risk patients, statins market to benefit?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. :
Statins: stick to the status quo?
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :
Inpharma, Vol. 1, Iss. 1220, 2000-01 ,pp. :